Products for Research Use Only
RegisterLogin
Hot

Lerdelimumab

CAT: 0804-HY-P99695Size: 1 EachDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99695Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Lerdelimumab (CAT-152) is an IgG4 human anti-TGF-β2 recombinant monoclonal antibody. Lerdelimumab can be used as an anti-scarring agent for glaucoma research[1][2].
CAS Number
285985-06-0
Product Name Alternative
CAT-152
UNSPSC
12352203
Target
TGF-beta/Smad
Type
Inhibitory Antibodies
Related Pathways
Stem Cell/Wnt; TGF-beta/Smad
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/lerdelimumab.html
Purity
97.27
Solubility
10 mM in DMSO
Smiles
[Lerdelimumab]
References & Citations
[1]Mead AL, et al. Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery. Invest Ophthalmol Vis Sci. 2003 Aug;44 (8) :3394-401.|[2]Wormstone IM, et al. TGF-beta2-induced matrix modification and cell transdifferentiation in the human lens capsular bag. Invest Ophthalmol Vis Sci.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Alternative Products

CatalogName
abx831094-01Lerdelimumab
591959Lerdelimumab (TGFB2)
GTR18337707Lerdelimumab Antibody
MBS1563758-01Research Grade Lerdelimumab
E55B0274Lerdelimumab (Reference antibody)
GTR18780640-01(Lerdelimumab) Biosimilar Reference Antibody
ICH5250-20mgLerdelimumab Biosimilar - Research Grade
GTR18697987-01Lerdelimumab Human Monoclonal Antibody
A134840Lerdelimumab Biosimilar (Monoclonal, IgG4-lambda)
GTR18117467Lerdelimumab (TGFB2) - Research Grade Biosimilar Antibody

Popular Products